Task C11 completion of the synthesis of 400 grams of non-GMP antibiotic candidate FG-960-2
Ended Awarded Last action
- Contract number
- 75N93020F00001
- Awardee
-
Curia Global Inc. UEI ELCNZCS8GEA3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $154,712
Award facts
- Contract value 100% obligated
- $154,712.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Albany, NY 12212, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$31,525 | |
| Other Administrative Action | $0 | |
| Change Order | $23,525 | |
| Original award | $162,712 |
About this award
This is a cost-plus-fixed-fee delivery order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Curia Global Inc. (doing business as Amri). The order is for the completion of the synthesis of 400 grams of non-GMP (good manufacturing practice) antibiotic candidate FG-960-2. The total ceiling value of the order is $154,712.13, with a period of performance ending on January 30, 2021. This order is part of a larger Nonclinical Services for Development of Interventional Agents contract vehicle. Curia Global Inc. is a for-profit organization and manufacturer of goods that specializes in pharmaceutical research and development services, particularly in areas like neurology, infectious diseases, and translational sciences. The contract does not have a small business set-aside designation, indicating that Curia Global Inc. competes effectively as a large business contractor.
Quick answers
Who was awarded contract 75N93020F00001?
75N93020F00001 was awarded to Curia Global Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 1, 2020.
How much is contract 75N93020F00001 worth?
The government has obligated $154,712 on 75N93020F00001.
Is contract 75N93020F00001 an order under another contract?
Yes. 75N93020F00001 is a delivery order under 75N93018D00008, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93020F00001 competed?
The extent of competition for 75N93020F00001 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award